Groups
Publications
-
Mirantes, C; Dosil, MA; Hills, D; Yang, J; Eritja, N; Santacana, M; Gatius, S; Vilardell, F; Medvinsky, A; Matias-Guiu, X; Dolcet, X
Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma but not myeloid malignancies
Blood 127 1907-1911. .
-
Eritja, N; Arjo, G; Santacana, M; Gatius, S; Ramirez-Nunez, O; Arcal, L; Serrano, JCE; Pamplona, R; Dolcet, X; Pinol, C; Christou, P; Matias-Guiu, X; Portero-Otin, M
Oral intake of genetically engineered high-carotenoid corn ameliorates hepatomegaly and hepatic steatosis in PTEN haploinsufficient mice
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1862 526-535. .
-
Del Carmen S; Gatius S; Franch-Arcas G; Baena JA; Gonzalez O; Zafon C; Cuevas D; Valls J; Pérez A; Martinez M; Ros S; Macías CG; Iglesias C; Matías-Guiu X; de Álava E
Concordance study between one-step nucleic acid amplification and morphologic techniques to detect lymph node metastasis in papillary carcinoma of the thyroid
HUMAN PATHOLOGY 48 132-141. .
-
Gatius, S; Matias-Guiu, X
Practical issues in the diagnosis of serous carcinoma of the endometrium
Modern Pathology 29 45-58. .
-
Porcel JM; Palma R; Bielsa S; Esquerda A; Gatius S; Matias-Guiu X; Salud A
TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions
RESPIROLOGY 20 831-833. .
-
Coenegrachts L; Garcia-Dios DA; Depreeuw J; Santacana M; Gatius S; Zikan M; Moerman P; Verbist L; Lambrechts D; Matias-Guiu X; Amant F
Mutation profile and clinical outcome of mixed endometrioid-serous endometrial carcinomas are different from that of pure endometrioid or serous carcinomas
VIRCHOWS ARCHIV 466 415-422. .
-
Santacana M; Maiques O; Valls J; Gatius S; Abó AI; López-García MÁ; Mota A; Reventós J; Moreno-Bueno G; Palacios J; Bartosch C; Dolcet X; Matias-Guiu X
A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry
HUMAN PATHOLOGY 45 2394-2403. .
-
Maiques, O.; Cuevas, D.; García Dios, D.A.; Coenegrachts, L.; Santacana, M.; Velasco, A.; Romero, M.; Gatius, S.; Lambrechts, D.; Müller, S.; Pedersen, H.C.; Dolcet, X.; Amant, F.; Matias-Guiu, X.
FISH analysis of PTEN in endometrial carcinoma. Comparison with SNP arrays and MLPA
Histopathology 65 371-388. .
-
Moreno, S.; Forcada, P.; Soria, X.; Altemir, V.; Gatius, S.; Gil, M.; Matías-Guiu, X.; Casanova, J.M.; Martí, R.M.
Tenosynovitis with rice body formation presenting as a cutaneous abscess
JOURNAL OF CUTANEOUS PATHOLOGY 41 602-605. .
-
Micci F; Gorunova L; Gatius S; Matias-Guiu X; Davidson B; Heim S; Panagopoulos I
MEAF6/PHF1 is a recurrent gene fusion in endometrial stromal sarcoma
CANCER LETTERS 347 75-78. .
-
De Petris, G.; Gatius Caldero, S.; Chen, L.; Xiao, S.-Y.; Dhungel, B.M.; Wendel Spizcka, A.J.; Lam-Himlin, D.
Histopathological Changes in the Gastrointestinal Tract Due to Drugs: An Update for the Surgical Pathologist ( Part I of II)
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY 22 120-128. .
-
Maiques O; Santacana M; Valls J; Pallares J; Mirantes C; Gatius S; García Dios DA; Amant F; Pedersen HC; Dolcet X; Matias-Guiu X
Optimal protocol for PTEN immunostaining; role of analytical and preanalyticat variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues
HUMAN PATHOLOGY 45 522-532. .
Projects
- Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- Clinical and functional identification of metastatic colonization biomarkers.
- Papel de ARID1A en la carcinogénesis endometrial dependiente de contexto. Análisis de los mecanismos moleculares y posibles implicaciones terapéuticas
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- IMPLEMENTATION OF PERSONALIZE MEDICINE IN CUTANEOUS MELANOMA BASED ON GENOMIC SUSCEPTIBILITY AND TUMOR SIGNATURES: IDENTIFICATION OF NEW TARGETS FOR MELANOMA TREATMENT
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
- Estudio metabolómico del carcinoma de endometrio en relación a parametros morfológicos y moleculares